As avian influenza threat grows, Moderna secures $590 million to develop pandemic influenza vaccines using messenger RNA (mRNA).

No person-to-person spread has been detected, but this does not mean that an H5N1 avian influenza pandemic is not possible or even likely. Read more



https://fortune.com/img-assets/wp-content/uploads/2025/01/GettyImages-2155807593-e1737564748281.jpg?resize=1200,600

Source link